NAN Nanoscience

    Embargoed Release: 07:00hrs Wednesday 12 December 2007

                               Nanoscience Inc.                                

                        (`Nanoscience' or the `Group')                         

                                 Patent Grant                                  

Nanoscience, the specialist niche investor in emerging technologies with strong
commercial propositions from within the growing nanotechnology sector, is
pleased to announce that its wholly owned subsidiary, Toumaz Technology Limited
(`Toumaz') has been granted its core patent surrounding the AMx(tm) (Advanced
Mixed Signal) technology in the key jurisdiction of Australia. The new patent,
already granted in the UK and the US, covers the core technology that enables
the Sensium(tm) platform to operate using orders of magnitude lower power than
existing semi-conductor solutions, leading to a dramatic reduction in battery
size for portable devices and extended operating times.

Earlier this year, Toumaz announced an agreement with Healthe International - a
leading health and wellness group operating in Australia and the Asia Pacific
market - to develop Sensium(tm) based applications for elite athlete training and
optimisation of sports performance.

Toumaz's groundbreaking Sensium(tm) technology is enabling a new generation of
low-cost, non-intrusive, wireless vital sign monitors for healthcare and
lifestyle markets - such as ECG, heart rate, body temperature, respiration and
physical activity - via standard handheld devices such as mobile phones. As
well as facilitating real time data measurement and processing, the AMx(tm) offers
designers greater efficiency, reduced complexity and reduced silicon area for
many applications. The sizeable reduction in peak operating current also allows
the use of ultra small form factor/thin flexible batteries whilst maintaining
months or years of operational life for the portable sensors. The unique
combination of ultra-low power wireless and signal processing in one small
System-On-Chip allows the economies of scale of the semiconductor industry to
be harnessed to provide low cost, highly functional, robust, disposable and
non-intrusive monitors for a wide range of healthcare and lifestyle management
applications.

The Group views the grant of this core patent by the Australian Patent Office
as a significant development in providing Toumaz with the necessary protection
of its core technology in what is considered to be a potentially major global
market.

Keith Errey, Chief Operating Officer of Toumaz, commented:

`The protection of our proprietary core technology in the world's key markets
is fundamental as we move into this key phase of market development for Sensium
(tm)enabled products.'

                                    -Ends-                                     

Further information:

Guy Spelman               Nanoscience Inc.          07767 338 967            
                                                                             
Simon Raggett             Strand Partners Limited   0207 409 3494            
                                                                             
Matthew Chandler                                                             
                                                                             
Andrew Tan                Hansard Group             020 7245 1100            
                                                                             
www.hansardgroup.co.uk                                                       

About Nanoscience Inc.:

Nanoscience is a specialist nice investor in emerging technologies with a
strong commercial proposition from within the medical technology and
semiconductor sectors.

About Toumaz:

Toumaz Technology Limited is the leading provider of ultra-low power wireless
infrastructure for body monitoring solutions.

Toumaz's ultra low-power smart sensor interface and transceiver platform - the
Sensium(tm) - enables non-intrusive, real-time wireless monitoring of multiple
vital signs for a wide range of healthcare and lifestyle management
applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal
(AMx(tm)) technology, the Sensium(tm) provides the enabling technology to connect the
mobile individual to healthcare providers - simply, affordably and
unobtrusively.

For healthcare professionals, this transforms the possibilities for pro-active
monitoring and improved quality of care. For patients, it delivers new
opportunities for lifestyle-compatible, personalised healthcare, as well as
better therapeutic outcomes.



END

Nanoscience (LSE:NAN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Nanoscience (LSE:NAN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024